Impact of neoadjuvant relugolix on patient-reported sexual function and bother

Autor: Jessica Y. Hsueh, Lindsey Gallagher, Min Ji Koh, Shaine Eden, Sarthak Shah, Markus Wells, Malika Danner, Alan Zwart, Marilyn Ayoob, Deepak Kumar, Paul Leger, Nancy A. Dawson, Simeng Suy, Rachel Rubin, Sean P. Collins

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

IntroductionSexual function following local treatment for prostate cancer is an important quality of life concern. Relugolix is a novel oral GnRH receptor antagonist used in combination with radiation therapy in the treatment of unfavorable prostate

Externí odkaz: https://doaj.org/article/4782e21c9b1f4d8ea9588eaf887b56ca

Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States.

Autor: Rachel M Burke, Sharon Balter, Emily Barnes, Vaughn Barry, Karri Bartlett, Karlyn D Beer, Isaac Benowitz, Holly M Biggs, Hollianne Bruce, Jonathan Bryant-Genevier, Jordan Cates, Kevin Chatham-Stephens, Nora Chea, Howard Chiou, Demian Christiansen, Victoria T Chu, Shauna Clark, Sara H Cody, Max Cohen, Erin E Conners, Vishal Dasari, Patrick Dawson, Traci DeSalvo, Matthew Donahue, Alissa Dratch, Lindsey Duca, Jeffrey Duchin, Jonathan W Dyal, Leora R Feldstein, Marty Fenstersheib, Marc Fischer, Rebecca Fisher, Chelsea Foo, Brandi Freeman-Ponder, Alicia M Fry, Jessica Gant, Romesh Gautom, Isaac Ghinai, Prabhu Gounder, Cheri T Grigg, Jeffrey Gunzenhauser, Aron J Hall, George S Han, Thomas Haupt, Michelle Holshue, Jennifer Hunter, Mireille B Ibrahim, Max W Jacobs, M Claire Jarashow, Kiran Joshi, Talar Kamali, Vance Kawakami, Moon Kim, Hannah L Kirking, Amanda Kita-Yarbro, Rachel Klos, Miwako Kobayashi, Anna Kocharian, Misty Lang, Jennifer Layden, Eva Leidman, Scott Lindquist, Stephen Lindstrom, Ruth Link-Gelles, Mariel Marlow, Claire P Mattison, Nancy McClung, Tristan D McPherson, Lynn Mello, Claire M Midgley, Shannon Novosad, Megan T Patel, Kristen Pettrone, Satish K Pillai, Ian W Pray, Heather E Reese, Heather Rhodes, Susan Robinson, Melissa Rolfes, Janell Routh, Rachel Rubin, Sarah L Rudman, Denny Russell, Sarah Scott, Varun Shetty, Sarah E Smith-Jeffcoat, Elizabeth A Soda, Christopher Spitters, Bryan Stierman, Rebecca Sunenshine, Dawn Terashita, Elizabeth Traub, Grace M Vahey, Jennifer R Verani, Megan Wallace, Matthew Westercamp, Jonathan Wortham, Amy Xie, Anna Yousaf, Matthew Zahn

Publikováno v: PLoS ONE, Vol 15, Iss 9, p e0238342 (2020)

Coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has since become pandemic. In response to the first cases identified in the

Externí odkaz: https://doaj.org/article/2703c8011f4143ec83d0dd77d95f6626

Paroxetine and bupropion have no in vitro effects on lynphocyte proliferation and viability Paroxetina e bupropiona não apresentam efeito na viabilidade nem na proliferação de linfócitos in vitro

Autor: Ramiro Ronchetti, Mariana Dal Pizzol, Rodrigo Pestana Lopes, Rachel Rubin da Silva, Gabriel José Chittó Gauer, Moisés Evandro Bauer

Publikováno v: Jornal Brasileiro de Psiquiatria, Vol 56, Iss 2, Pp 116-119 (2007)

OBJECTIVE: Initial studies with tricyclic antidepressants demonstrated that they jeopardize the immune system activity. Recent studies suggested that selective serotonin reuptake inhibitors would have stimulating immunological effects. Here, we explo

Externí odkaz: https://doaj.org/article/6e3fcf4540264543b65632d8b7a40054

Coping, resilience, and social support among transgender and gender diverse individuals experiencing gender-related stress

Autor: Kaitlyn R. Gorman, Rachel Rubin, Jillian C. Shipherd, Brian A. Rood, Kathleen M. Collins, David W. Pantalone, Hamish A. Gunn

Publikováno v: Psychology of Sexual Orientation and Gender Diversity. 9:37-48

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84745b27c33d789525db24fdd50fde8c
https://doi.org/10.1037/sgd0000455

Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin

Autor: Irwin Goldstein, Silvia Diviccaro, Silvia Giatti, Audrey S. Bahrick, Barbara D'Avanzo, Caroline F. Pukall, David Healy, Heiko Graf, Angelo Barbato, David Edmund Johannes Linden, Amy M. Pearlman, Barbara M. Chubak, Michał Lew-Starowicz, Mohit Khera, Stuart Shipko, Fiammetta Cosci, Omar Walid Muquebil Ali Al Shaban Rodríguez, Joanna Le Noury, Michael S. Irwig, Arianna Patacchini, Paddy K.C. Janssen, Rudy Schreiber, Celine Lüning, Maarten Bak, Jalesh N. Panicker, Dee Mangin, Ahad Waraich, Manoj Therayil Kumar, Barbora Vašečková, Rachel Rubin, Yacov Reisman, Emmanuele A. Jannini, Wayne J.G. Hellstrom, Roberto Cosimo Melcangi, Sanjana Raj, Rocco Salvatore Calabrò, Antonei B. Csoka

Publikováno v: International Journal of Risk and Safety in Medicine, 33(1), 65-76. IOS Press

BACKGROUND: A set of enduring conditions have been reported in the literature involving persistent sexual dysfunction after discontinuation of serotonin reuptake inhibiting antidepressants, 5 alpha-reductase inhibitors and isotretinoin.OBJECTIVE: To

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03a82e516494191e9525366a0e9c1d1c
https://cris.maastrichtuniversity.nl/en/publications/7e69d2e3-daaa-486e-9869-3bc6c7210727